PROTACs, molecular glues and other degraders

m-PEG4-PFP ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:LiquidIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3 ubiquitin ligase and the

Mal-NH-PEG8-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:OilIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3 ubiquitin ligase and the

Mal-NH-PEG8-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:OilIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3 ubiquitin ligase and the

Mal-PEG10-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:OilIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3 ubiquitin ligase and the

Mal-PEG10-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:OilIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3 ubiquitin ligase and the

Mal-PEG10-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:OilIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3 ubiquitin ligase and the

MD-222.

MD-222.

MG-277.

MG-277.

ML 2-14 is a PROTAC for degrading BRD4 , with C4 alkyl linker. ML 2-14 exerts degradation of BRD4 in 231MFP breast cancer cells.Appearance:SolidIn Vitro:ML 2-14 with C4 alkyl linker showes robust degradation of BRD4 in 231MFP breast cancer cells,

ML 2-14 is a PROTAC for degrading BRD4 , with C4 alkyl linker. ML 2-14 exerts degradation of BRD4 in 231MFP breast cancer cells.Appearance:SolidIn Vitro:ML 2-14 with C4 alkyl linker showes robust degradation of BRD4 in 231MFP breast cancer cells,